These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 25961064

  • 1. Downmodulation of vaccine-induced immunity and protection against the intracellular bacterium Francisella tularensis by the inhibitory receptor FcγRIIB.
    Franz BJ, Li Y, Bitsaktsis C, Iglesias BV, Pham G, Sunagar R, Kumar S, Gosselin EJ.
    J Immunol Res; 2015; 2015():840842. PubMed ID: 25961064
    [Abstract] [Full Text] [Related]

  • 2. Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.
    Baron SD, Singh R, Metzger DW.
    Infect Immun; 2007 May; 75(5):2152-62. PubMed ID: 17296747
    [Abstract] [Full Text] [Related]

  • 3. Fc receptor-targeting of immunogen as a strategy for enhanced antigen loading, vaccination, and protection using intranasally administered antigen-pulsed dendritic cells.
    Pham GH, Iglesias BV, Gosselin EJ.
    Vaccine; 2014 Sep 08; 32(40):5212-20. PubMed ID: 25068496
    [Abstract] [Full Text] [Related]

  • 4. Utilization of Fc receptors as a mucosal vaccine strategy against an intracellular bacterium, Francisella tularensis.
    Rawool DB, Bitsaktsis C, Li Y, Gosselin DR, Lin Y, Kurkure NV, Metzger DW, Gosselin EJ.
    J Immunol; 2008 Apr 15; 180(8):5548-57. PubMed ID: 18390739
    [Abstract] [Full Text] [Related]

  • 5. Vaccination evokes gender-dependent protection against tularemia infection in C57BL/6Tac mice.
    Sunagar R, Kumar S, Franz BJ, Gosselin EJ.
    Vaccine; 2016 Jun 17; 34(29):3396-404. PubMed ID: 27182819
    [Abstract] [Full Text] [Related]

  • 6. Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.
    Richard K, Mann BJ, Qin A, Barry EM, Ernst RK, Vogel SN.
    Clin Vaccine Immunol; 2017 Mar 17; 24(3):. PubMed ID: 28077440
    [Abstract] [Full Text] [Related]

  • 7. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
    KuoLee R, Harris G, Conlan JW, Chen W.
    Vaccine; 2007 May 10; 25(19):3781-91. PubMed ID: 17346863
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. T-bet regulates immunity to Francisella tularensis live vaccine strain infection, particularly in lungs.
    Melillo AA, Foreman O, Bosio CM, Elkins KL.
    Infect Immun; 2014 Apr 10; 82(4):1477-90. PubMed ID: 24421047
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Survival of secondary lethal systemic Francisella LVS challenge depends largely on interferon gamma.
    Elkins KL, Colombini SM, Meierovics AI, Chu MC, Chou AY, Cowley SC.
    Microbes Infect; 2010 Jan 10; 12(1):28-36. PubMed ID: 19781659
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Increased susceptibility of IgA-deficient mice to pulmonary Francisella tularensis live vaccine strain infection.
    Furuya Y, Kirimanjeswara GS, Roberts S, Metzger DW.
    Infect Immun; 2013 Sep 10; 81(9):3434-41. PubMed ID: 23836815
    [Abstract] [Full Text] [Related]

  • 16. Models derived from in vitro analyses of spleen, liver, and lung leukocyte functions predict vaccine efficacy against the Francisella tularensis Live Vaccine Strain (LVS).
    De Pascalis R, Chou AY, Ryden P, Kennett NJ, Sjöstedt A, Elkins KL.
    mBio; 2014 Apr 08; 5(2):e00936. PubMed ID: 24713322
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.
    Tian D, Uda A, Park ES, Hotta A, Fujita O, Yamada A, Hirayama K, Hotta K, Koyama Y, Azaki M, Morikawa S.
    Microbiol Immunol; 2018 Jan 08; 62(1):24-33. PubMed ID: 29171073
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.